1. De novo deletions of p53 gene and wild-type p53 correlate with acquired cisplatin-resistance in human osteosarcoma OST cell line;Asada;Anticancer Res.,1999
2. Complete sequencing of TP53 predicts poor response to systemic therapy of advanced breast cancer;Berns;Cancer Res.,2000
3. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
4. Inactivation of the tumor suppressor p53 by long noncoding RNA RMRP;Chen;Proc. Natl. Acad. Sci. USA,2021
5. The epidermal growth factor receptor responsive miR-125a represses mesenchymal morphology in ovarian cancer cells;Cowden Dahl;Neoplasia,2009